
Celiac Disease Treatment Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type
Description
Celiac Disease Treatment Market Summary
and Market Overview
Celiac disease treatments include vitamins, gluten-degrading enzymes, and symptomatic therapies to manage a chronic autoimmune disorder affecting 1% of the global population, with diagnosis rates rising from 10% in 2000 to 30% in 2020. The market is driven by increasing nutritional health awareness, with 60% of consumers prioritizing gluten-free diets, and advancements in drug development, such as larazotide acetate, which improves symptoms in 30% of patients. The aging population, improved diagnostics, and rising prevalence of autoimmune diseases further boost demand. The global celiac disease treatment market is estimated at USD 400-700 million in 2025, with a CAGR of 8%-13% through 2030.
Regional Market Trends
North America: The U.S. leads with high diagnosis rates and gluten-free product adoption, while Canada focuses on dietary management.
Europe: Germany, France, and the UK drive growth with robust gastroenterology services.
Asia Pacific: China and India see rising demand due to increasing awareness, with Japan emphasizing novel therapies.
Rest of the World: Brazil expands public health access, while the Middle East addresses dietary health.
Distribution Channel Analysis
Hospital Pharmacies: Expected growth of 8.5%-13.5%, driven by symptomatic treatments. Trends focus on specialized care.
Retail Pharmacies: Projected growth of 8.2%-13.2%, linked to vitamins and enzymes. Advances emphasize patient convenience.
Other Distribution Channels: Anticipated growth of 7.8%-12.8%, covering online platforms. Trends highlight digital access.
Type Analysis
Vitamins & Minerals: Expected growth of 8.0%-13.0%, valued for nutritional support. Trends focus on fortified supplements.
Gluten Degrading Enzymes: Projected growth of 9.0%-14.0%, favored for dietary management. Advances emphasize oral formulations.
Symptomatic Treatment (Anti-inflammatory Drugs, Antihistamines, Others): Anticipated growth of 7.8%-12.8%, suited for symptom relief. Trends highlight combination therapies.
Other Treatments: Expected growth of 7.5%-12.5%, covering novel drugs. Developments prioritize gut barrier restoration.
Key Market Players
Teva Pharmaceutical: Offers symptomatic treatments for celiac disease.
Amgen: Develops novel therapies for autoimmune disorders.
Takeda Pharmaceutical: Focuses on gastrointestinal treatments.
Novartis: Provides anti-inflammatory drugs.
BioLineRx: Specializes in innovative celiac therapies.
Porter’s Five Forces Analysis
Threat of New Entrants: Moderate, due to high R&D costs, but dietary supplements lower barriers.
Threat of Substitutes: High, with gluten-free diets competing, but drugs address severe cases.
Bargaining Power of Buyers: Moderate, as patients seek effective therapies, but dietary options limit choices.
Bargaining Power of Suppliers: Low, with multiple providers of active ingredients.
Competitive Rivalry: Moderate, with players competing on efficacy and accessibility.
Market Opportunities and Challenges
Opportunities:
Addressing celiac disease, affecting 1% of the population.
Leveraging rising diagnosis rates, up to 30% in 2020.
Utilizing nutritional health awareness, with 60% consumer focus.
Supporting novel drugs like larazotide acetate.
Meeting demand from aging populations with autoimmune risks.
Expanding gluten-free product access in emerging markets.
Challenges:
High costs of novel therapies.
Regulatory delays for new drugs.
Patient adherence to gluten-free diets.
Competition from dietary management.
Limited awareness in low-income regions.
and Market Overview
Celiac disease treatments include vitamins, gluten-degrading enzymes, and symptomatic therapies to manage a chronic autoimmune disorder affecting 1% of the global population, with diagnosis rates rising from 10% in 2000 to 30% in 2020. The market is driven by increasing nutritional health awareness, with 60% of consumers prioritizing gluten-free diets, and advancements in drug development, such as larazotide acetate, which improves symptoms in 30% of patients. The aging population, improved diagnostics, and rising prevalence of autoimmune diseases further boost demand. The global celiac disease treatment market is estimated at USD 400-700 million in 2025, with a CAGR of 8%-13% through 2030.
Regional Market Trends
North America: The U.S. leads with high diagnosis rates and gluten-free product adoption, while Canada focuses on dietary management.
Europe: Germany, France, and the UK drive growth with robust gastroenterology services.
Asia Pacific: China and India see rising demand due to increasing awareness, with Japan emphasizing novel therapies.
Rest of the World: Brazil expands public health access, while the Middle East addresses dietary health.
Distribution Channel Analysis
Hospital Pharmacies: Expected growth of 8.5%-13.5%, driven by symptomatic treatments. Trends focus on specialized care.
Retail Pharmacies: Projected growth of 8.2%-13.2%, linked to vitamins and enzymes. Advances emphasize patient convenience.
Other Distribution Channels: Anticipated growth of 7.8%-12.8%, covering online platforms. Trends highlight digital access.
Type Analysis
Vitamins & Minerals: Expected growth of 8.0%-13.0%, valued for nutritional support. Trends focus on fortified supplements.
Gluten Degrading Enzymes: Projected growth of 9.0%-14.0%, favored for dietary management. Advances emphasize oral formulations.
Symptomatic Treatment (Anti-inflammatory Drugs, Antihistamines, Others): Anticipated growth of 7.8%-12.8%, suited for symptom relief. Trends highlight combination therapies.
Other Treatments: Expected growth of 7.5%-12.5%, covering novel drugs. Developments prioritize gut barrier restoration.
Key Market Players
Teva Pharmaceutical: Offers symptomatic treatments for celiac disease.
Amgen: Develops novel therapies for autoimmune disorders.
Takeda Pharmaceutical: Focuses on gastrointestinal treatments.
Novartis: Provides anti-inflammatory drugs.
BioLineRx: Specializes in innovative celiac therapies.
Porter’s Five Forces Analysis
Threat of New Entrants: Moderate, due to high R&D costs, but dietary supplements lower barriers.
Threat of Substitutes: High, with gluten-free diets competing, but drugs address severe cases.
Bargaining Power of Buyers: Moderate, as patients seek effective therapies, but dietary options limit choices.
Bargaining Power of Suppliers: Low, with multiple providers of active ingredients.
Competitive Rivalry: Moderate, with players competing on efficacy and accessibility.
Market Opportunities and Challenges
Opportunities:
Addressing celiac disease, affecting 1% of the population.
Leveraging rising diagnosis rates, up to 30% in 2020.
Utilizing nutritional health awareness, with 60% consumer focus.
Supporting novel drugs like larazotide acetate.
Meeting demand from aging populations with autoimmune risks.
Expanding gluten-free product access in emerging markets.
Challenges:
High costs of novel therapies.
Regulatory delays for new drugs.
Patient adherence to gluten-free diets.
Competition from dietary management.
Limited awareness in low-income regions.
Table of Contents
82 Pages
- Chapter 1 Executive Summary
- Chapter 2 Abbreviation and Acronyms
- Chapter 3 Preface
- 3.1 Research Scope
- 3.2 Research Sources
- 3.2.1 Data Sources
- 3.2.2 Assumptions
- 3.3 Research Method
- Chapter Four Market Landscape
- 4.1 Market Overview
- 4.2 Classification/Types
- 4.3 Application/End Users
- Chapter 5 Market Trend Analysis
- 5.1 Introduction
- 5.2 Drivers
- 5.3 Restraints
- 5.4 Opportunities
- 5.5 Threats
- Chapter 6 Industry Chain Analysis
- 6.1 Upstream/Suppliers Analysis
- 6.2 Celiac Disease Treatment Analysis
- 6.2.1 Technology Analysis
- 6.2.2 Cost Analysis
- 6.2.3 Market Channel Analysis
- 6.3 Downstream Buyers/End Users
- Chapter 7 Latest Market Dynamics
- 7.1 Latest News
- 7.2 Merger and Acquisition
- 7.3 Planned/Future Project
- 7.4 Policy Dynamics
- Chapter 8 Historical and Forecast Celiac Disease Treatment Market in North America (2020-2030)
- 8.1 Celiac Disease Treatment Market Size
- 8.2 Celiac Disease Treatment Market by End Use
- 8.3 Competition by Players/Suppliers
- 8.4 Celiac Disease Treatment Market Size by Type
- 8.5 Key Countries Analysis
- 8.5.1 United States
- 8.5.2 Canada
- 8.5.3 Mexico
- Chapter 9 Historical and Forecast Celiac Disease Treatment Market in South America (2020-2030)
- 9.1 Celiac Disease Treatment Market Size
- 9.2 Celiac Disease Treatment Market by End Use
- 9.3 Competition by Players/Suppliers
- 9.4 Celiac Disease Treatment Market Size by Type
- 9.5 Key Countries Analysis
- 9.5.1 Brazil
- 9.5.2 Argentina
- 9.5.3 Chile
- 9.5.4 Peru
- Chapter 10 Historical and Forecast Celiac Disease Treatment Market in Asia & Pacific (2020-2030)
- 10.1 Celiac Disease Treatment Market Size
- 10.2 Celiac Disease Treatment Market by End Use
- 10.3 Competition by Players/Suppliers
- 10.4 Celiac Disease Treatment Market Size by Type
- 10.5 Key Countries Analysis
- 10.5.1 China
- 10.5.2 India
- 10.5.3 Japan
- 10.5.4 South Korea
- 10.5.5 Southest Asia
- 10.5.6 Australia
- Chapter 11 Historical and Forecast Celiac Disease Treatment Market in Europe (2020-2030)
- 11.1 Celiac Disease Treatment Market Size
- 11.2 Celiac Disease Treatment Market by End Use
- 11.3 Competition by Players/Suppliers
- 11.4 Celiac Disease Treatment Market Size by Type
- 11.5 Key Countries Analysis
- 11.5.1 Germany
- 11.5.2 France
- 11.5.3 United Kingdom
- 11.5.4 Italy
- 11.5.5 Spain
- 11.5.6 Belgium
- 11.5.7 Netherlands
- 11.5.8 Austria
- 11.5.9 Poland
- 11.5.10 Russia
- Chapter 12 Historical and Forecast Celiac Disease Treatment Market in MEA (2020-2030)
- 12.1 Celiac Disease Treatment Market Size
- 12.2 Celiac Disease Treatment Market by End Use
- 12.3 Competition by Players/Suppliers
- 12.4 Celiac Disease Treatment Market Size by Type
- 12.5 Key Countries Analysis
- 12.5.1 Egypt
- 12.5.2 Israel
- 12.5.3 South Africa
- 12.5.4 Gulf Cooperation Council Countries
- 12.5.5 Turkey
- Chapter 13 Summary For Global Celiac Disease Treatment Market (2020-2025)
- 13.1 Celiac Disease Treatment Market Size
- 13.2 Celiac Disease Treatment Market by End Use
- 13.3 Competition by Players/Suppliers
- 13.4 Celiac Disease Treatment Market Size by Type
- Chapter 14 Global Celiac Disease Treatment Market Forecast (2025-2030)
- 14.1 Celiac Disease Treatment Market Size Forecast
- 14.2 Celiac Disease Treatment Application Forecast
- 14.3 Competition by Players/Suppliers
- 14.4 Celiac Disease Treatment Type Forecast
- Chapter 15 Analysis of Global Key Vendors
- 15.1 Teva Pharmaceutical
- 15.1.1 Company Profile
- 15.1.2 Main Business and Celiac Disease Treatment Information
- 15.1.3 SWOT Analysis of Teva Pharmaceutical
- 15.1.4 Teva Pharmaceutical Celiac Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
- 15.2 Amgen
- 15.2.1 Company Profile
- 15.2.2 Main Business and Celiac Disease Treatment Information
- 15.2.3 SWOT Analysis of Amgen
- 15.2.4 Amgen Celiac Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
- 15.3 Amneal Pharmaceuticals
- 15.3.1 Company Profile
- 15.3.2 Main Business and Celiac Disease Treatment Information
- 15.3.3 SWOT Analysis of Amneal Pharmaceuticals
- 15.3.4 Amneal Pharmaceuticals Celiac Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
- 15.4 GLENMARK PHARMACEUTICALS
- 15.4.1 Company Profile
- 15.4.2 Main Business and Celiac Disease Treatment Information
- 15.4.3 SWOT Analysis of GLENMARK PHARMACEUTICALS
- 15.4.4 GLENMARK PHARMACEUTICALS Celiac Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
- 15.5 Takeda Pharmaceutical
- 15.5.1 Company Profile
- 15.5.2 Main Business and Celiac Disease Treatment Information
- 15.5.3 SWOT Analysis of Takeda Pharmaceutical
- 15.5.4 Takeda Pharmaceutical Celiac Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
- Please ask for sample pages for full companies list
- Tables and Figures
- Table Abbreviation and Acronyms
- Table Research Scope of Celiac Disease Treatment Report
- Table Data Sources of Celiac Disease Treatment Report
- Table Major Assumptions of Celiac Disease Treatment Report
- Figure Market Size Estimated Method
- Figure Major Forecasting Factors
- Figure Celiac Disease Treatment Picture
- Table Celiac Disease Treatment Classification
- Table Celiac Disease Treatment Applications
- Table Drivers of Celiac Disease Treatment Market
- Table Restraints of Celiac Disease Treatment Market
- Table Opportunities of Celiac Disease Treatment Market
- Table Threats of Celiac Disease Treatment Market
- Table Covid-19 Impact For Celiac Disease Treatment Market
- Table Raw Materials Suppliers
- Table Different Production Methods of Celiac Disease Treatment
- Table Cost Structure Analysis of Celiac Disease Treatment
- Table Key End Users
- Table Latest News of Celiac Disease Treatment Market
- Table Merger and Acquisition
- Table Planned/Future Project of Celiac Disease Treatment Market
- Table Policy of Celiac Disease Treatment Market
- Table 2020-2030 North America Celiac Disease Treatment Market Size
- Figure 2020-2030 North America Celiac Disease Treatment Market Size and CAGR
- Table 2020-2030 North America Celiac Disease Treatment Market Size by Application
- Table 2020-2025 North America Celiac Disease Treatment Key Players Revenue
- Table 2020-2025 North America Celiac Disease Treatment Key Players Market Share
- Table 2020-2030 North America Celiac Disease Treatment Market Size by Type
- Table 2020-2030 United States Celiac Disease Treatment Market Size
- Table 2020-2030 Canada Celiac Disease Treatment Market Size
- Table 2020-2030 Mexico Celiac Disease Treatment Market Size
- Table 2020-2030 South America Celiac Disease Treatment Market Size
- Figure 2020-2030 South America Celiac Disease Treatment Market Size and CAGR
- Table 2020-2030 South America Celiac Disease Treatment Market Size by Application
- Table 2020-2025 South America Celiac Disease Treatment Key Players Revenue
- Table 2020-2025 South America Celiac Disease Treatment Key Players Market Share
- Table 2020-2030 South America Celiac Disease Treatment Market Size by Type
- Table 2020-2030 Brazil Celiac Disease Treatment Market Size
- Table 2020-2030 Argentina Celiac Disease Treatment Market Size
- Table 2020-2030 Chile Celiac Disease Treatment Market Size
- Table 2020-2030 Peru Celiac Disease Treatment Market Size
- Table 2020-2030 Asia & Pacific Celiac Disease Treatment Market Size
- Figure 2020-2030 Asia & Pacific Celiac Disease Treatment Market Size and CAGR
- Table 2020-2030 Asia & Pacific Celiac Disease Treatment Market Size by Application
- Table 2020-2025 Asia & Pacific Celiac Disease Treatment Key Players Revenue
- Table 2020-2025 Asia & Pacific Celiac Disease Treatment Key Players Market Share
- Table 2020-2030 Asia & Pacific Celiac Disease Treatment Market Size by Type
- Table 2020-2030 China Celiac Disease Treatment Market Size
- Table 2020-2030 India Celiac Disease Treatment Market Size
- Table 2020-2030 Japan Celiac Disease Treatment Market Size
- Table 2020-2030 South Korea Celiac Disease Treatment Market Size
- Table 2020-2030 Southeast Asia Celiac Disease Treatment Market Size
- Table 2020-2030 Australia Celiac Disease Treatment Market Size
- Table 2020-2030 Europe Celiac Disease Treatment Market Size
- Figure 2020-2030 Europe Celiac Disease Treatment Market Size and CAGR
- Table 2020-2030 Europe Celiac Disease Treatment Market Size by Application
- Table 2020-2025 Europe Celiac Disease Treatment Key Players Revenue
- Table 2020-2025 Europe Celiac Disease Treatment Key Players Market Share
- Table 2020-2030 Europe Celiac Disease Treatment Market Size by Type
- Table 2020-2030 Germany Celiac Disease Treatment Market Size
- Table 2020-2030 France Celiac Disease Treatment Market Size
- Table 2020-2030 United Kingdom Celiac Disease Treatment Market Size
- Table 2020-2030 Italy Celiac Disease Treatment Market Size
- Table 2020-2030 Spain Celiac Disease Treatment Market Size
- Table 2020-2030 Belgium Celiac Disease Treatment Market Size
- Table 2020-2030 Netherlands Celiac Disease Treatment Market Size
- Table 2020-2030 Austria Celiac Disease Treatment Market Size
- Table 2020-2030 Poland Celiac Disease Treatment Market Size
- Table 2020-2030 Russia Celiac Disease Treatment Market Size
- Table 2020-2030 MEA Celiac Disease Treatment Market Size
- Figure 2020-2030 MEA Celiac Disease Treatment Market Size and CAGR
- Table 2020-2030 MEA Celiac Disease Treatment Market Size by Application
- Table 2020-2025 MEA Celiac Disease Treatment Key Players Revenue
- Table 2020-2025 MEA Celiac Disease Treatment Key Players Market Share
- Table 2020-2030 MEA Celiac Disease Treatment Market Size by Type
- Table 2020-2030 Egypt Celiac Disease Treatment Market Size
- Table 2020-2030 Israel Celiac Disease Treatment Market Size
- Table 2020-2030 South Africa Celiac Disease Treatment Market Size
- Table 2020-2030 Gulf Cooperation Council Countries Celiac Disease Treatment Market Size
- Table 2020-2030 Turkey Celiac Disease Treatment Market Size
- Table 2020-2025 Global Celiac Disease Treatment Market Size by Region
- Table 2020-2025 Global Celiac Disease Treatment Market Size Share by Region
- Table 2020-2025 Global Celiac Disease Treatment Market Size by Application
- Table 2020-2025 Global Celiac Disease Treatment Market Share by Application
- Table 2020-2025 Global Celiac Disease Treatment Key Vendors Revenue
- Figure 2020-2025 Global Celiac Disease Treatment Market Size and Growth Rate
- Table 2020-2025 Global Celiac Disease Treatment Key Vendors Market Share
- Table 2020-2025 Global Celiac Disease Treatment Market Size by Type
- Table 2020-2025 Global Celiac Disease Treatment Market Share by Type
- Table 2025-2030 Global Celiac Disease Treatment Market Size by Region
- Table 2025-2030 Global Celiac Disease Treatment Market Size Share by Region
- Table 2025-2030 Global Celiac Disease Treatment Market Size by Application
- Table 2025-2030 Global Celiac Disease Treatment Market Share by Application
- Table 2025-2030 Global Celiac Disease Treatment Key Vendors Revenue
- Figure 2025-2030 Global Celiac Disease Treatment Market Size and Growth Rate
- Table 2025-2030 Global Celiac Disease Treatment Key Vendors Market Share
- Table 2025-2030 Global Celiac Disease Treatment Market Size by Type
- Table 2025-2030 Celiac Disease Treatment Global Market Share by Type
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.